0.68 - 0.75
0.33 - 0.86
12.80M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.81%
Negative revenue growth while 0335.HK stands at 238.28%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-20.70%
Negative gross profit growth while 0335.HK is at 238.28%. Joel Greenblatt would examine cost competitiveness or demand decline.
-93.78%
Negative EBIT growth while 0335.HK is at 496.75%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-93.78%
Negative operating income growth while 0335.HK is at 496.55%. Joel Greenblatt would press for urgent turnaround measures.
-52.25%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-41.23%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-51.99%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-18.65%
Share reduction while 0335.HK is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.28%
Reduced diluted shares while 0335.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-759.79%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-409.50%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-44.67%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-61.60%
Negative 5Y CAGR while 0335.HK stands at 247.64%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-57.14%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-248.64%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-1024.04%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-303.16%
Negative 3Y OCF/share CAGR while 0335.HK stands at 56.77%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-78.89%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-57.34%
Negative 5Y net income/share CAGR while 0335.HK is 297.99%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-26.08%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
-0.74%
Negative 5Y equity/share growth while 0335.HK is at 87.43%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-19.59%
Negative 3Y equity/share growth while 0335.HK is at 13.38%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
27.51%
Below 50% of 0335.HK's 353.05%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
81.33%
Below 50% of 0335.HK's 349.99%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
65.59%
3Y dividend/share CAGR at 75-90% of 0335.HK's 80.00%. Bill Ackman wants overhead or revenue enhancements to match competitor's dividend growth.
45.51%
AR growth of 45.51% while 0335.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-23.96%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
6.27%
Asset growth above 1.5x 0335.HK's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
22.10%
Positive BV/share change while 0335.HK is negative. John Neff sees a clear edge over a competitor losing equity.
89.98%
We have some new debt while 0335.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-34.95%
Our R&D shrinks while 0335.HK invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
7.22%
SG&A declining or stable vs. 0335.HK's 29.24%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.